Trial · NCT06770426
CompARing Between CO2 Phenylephrine and Phenylephrine Only Treatment in Patients With proGrEssing Cerebral infarctioN
NCT06770426, Phase 3, Not yet recruiting, Yonsei University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. CompARing Between CO2 Phenylephrine and Phenylephrine Only Treatment in Patients With proGrEssing Cerebral infarctioN. Trials, record NCT06770426. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06770426
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- CompARing Between CO2 Phenylephrine and Phenylephrine Only Treatment in Patients With proGrEssing Cerebral infarctioN
- NCT number
- NCT06770426
- Status
- Not yet recruiting
- Phases
- Phase 3
- Enrollment
- 40 participants, estimated
- Lead sponsor
- Yonsei University
- Conditions
- Acute Ischemic Stroke
- Interventions
- carbogen with or without phenyleprhine, phenylephrine
- First posted
- 2025-01-13
- Last updated
- 2025-01-20
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | percent improvement of NIHSS score in each group | 24 hours | (baseline NIHSS score-post-treatment NIHSS score)/baseline NIHSS score×100 |
| Primary | difference of NIHSS score in each group | 24 hours | baseline NIHSS score-post-treatment NIHSS score |
| Primary | percent improvement of MRC score in each group | within 24 hours | (baseline MRC score-post-treatment MRC score)/baseline MRC score×100 |
| Primary | difference of MRC score in each group | difference of MRC score in each group | baseline MRC score-post-treatment MRC score |
| Primary | Saftety outcome: Side effect | within 7 days | Side effect (cerebral hemorrhage, myocardial infarction, Losing consciousness, difficulty breathing, dizziness, fatigue, headache, anxiety, etc) |
| Primary | Saftety outcome: discontinuing patients | within 7 days | Number of discontinuing patients due to side effects |
| Secondary | Comparision between groups by percent improvement of NIHSS score | 24 hours | (baseline NIHSS score-post-treatment NIHSS score)/baseline NIHSS score×100 |
| Secondary | Comparision between groups by differnece of NIHSS score | 24 hours | baseline NIHSS score-post-treatment NIHSS score |
| Secondary | Comparision between groups by percent improvement in MRC score | within 24 hours | (baseline MRC score-post-treatment MRC score)/baseline MRC score×100 |
| Secondary | Comparision between groups by difference of MRC score | within 24 hours | baseline MRC score-post-treatment MRC score |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06770426
GET https://conductscience.org/api/trials/v1/NCT06770426/registered